Research Lobe Sciences partners with iNGENū for new clinical trials in Australia Canadian biopharmaceutical company will receive government tax incentive for studies down under Rowan DunneAugust 12, 2022
Psychedelics Serenus Global becomes Health Canada licensed psilocybin distributor Multi-disciplinary controlled substance company set to commence operations at Calgary facility Rowan DunneAugust 11, 2022
Culture Sisters in Psychedelics host inaugural summit in Vancouver this September Upcoming event said to feature powerful female speakers from broad cross-section of practices and expertise Rowan DunneAugust 10, 2022
Canada PharmAla Biotech initiates MDMA supplier agreement with InterVivo Biotechnology company will supply InterVivo and clients with clinical-grade MDMA for scientific analyses Rowan DunneAugust 5, 2022
Psychedelics WITHIN ‘Ceremonial Psychedelic Treatment Center’ opens in Texas New clients offer detailed enthusiastic feedback thus far Rowan DunneAugust 2, 2022
Psychedelics DOSED 2 set to premiere at Vogue Theatre in Vancouver Award-winning documentary sequel to be followed by Q&A with renowned psychedelic community figures Rowan DunneJuly 29, 2022
Canada TheraPsil launches Project Solace, Filament Health offers support 'Largest' psilocybin access and data campaign intended to forward mission of promoting fungi-assisted psychotherapy Rowan DunneJuly 28, 2022
Psychedelics Sage Institute receives grant to help continue its psychedelic therapy in California Cohen Foundation proudly supports organization dedicated to aiding underserved communities Rowan DunneJuly 27, 2022
Psychedelics Field Trip administers new synthetic molecule in Australia Initial dose of FT-104 given in Adelaide, company announces name change Rowan DunneJuly 22, 2022
Psychedelics Delic Holdings highlights financial success and continues expanding KWC Canadian company continues to develop its presence in the clinical psychedelic sector Rowan DunneJuly 21, 2022